Study of YH004 (4-1BB Agonist Antibody) in Advanced Solid Tumors And Relapsed Or Refractory Non-Hodgkin Lymphoma
Clinical trial NCT05564806 · UNKNOWN
Trial details
- NCT number
- NCT05564806
- Sponsor
- Eucure (Beijing) Biopharma Co., Ltd
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-31
- Primary completion
- 2025-10-24
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.